Tharimmune Statistics
Share Statistics
Tharimmune has 1.49M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 1.49M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 18.71K |
| FTD / Avg. Volume | 1.47% |
Short Selling Information
The latest short interest is 496.87K, so 33.44% of the outstanding shares have been sold short.
| Short Interest | 496.87K |
| Short % of Shares Out | 33.44% |
| Short % of Float | 34.23% |
| Short Ratio (days to cover) | 0.19 |
Valuation Ratios
The PE ratio is -0.07 and the forward PE ratio is -16.08.
| PE Ratio | -0.07 |
| Forward PE | -16.08 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.07 |
| P/FCF Ratio | -0.09 |
| PEG Ratio | n/a |
Enterprise Valuation
Tharimmune Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.
| Current Ratio | 6.03 |
| Quick Ratio | 6.03 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -572.87 |
Financial Efficiency
Return on equity (ROE) is -1.02% and return on capital (ROIC) is -103.55%.
| Return on Equity (ROE) | -1.02% |
| Return on Assets (ROA) | -0.85% |
| Return on Capital (ROIC) | -103.55% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -4.66M |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -73.58% in the last 52 weeks. The beta is 1.45, so Tharimmune 's price volatility has been higher than the market average.
| Beta | 1.45 |
| 52-Week Price Change | -73.58% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 3.81 |
| Relative Strength Index (RSI) | 46.29 |
| Average Volume (20 Days) | 1.27M |
Income Statement
In the last 12 months, Tharimmune had revenue of $0 and earned -$9.32M in profits. Earnings per share was $-107.08.
| Revenue | 0 |
| Gross Profit | 0 |
| Operating Income | -9.46M |
| Net Income | -9.32M |
| EBITDA | -9.30M |
| EBIT | - |
| Earnings Per Share (EPS) | -107.08 |
Balance Sheet
The company has $10.94M in cash and $0 in debt, giving a net cash position of $10.94M.
| Cash & Cash Equivalents | 10.94M |
| Total Debt | 0 |
| Net Cash | 10.94M |
| Retained Earnings | -24.70M |
| Total Assets | 5.25M |
| Working Capital | 3.02M |
Cash Flow
In the last 12 months, operating cash flow was -$7.30M and capital expenditures -$4, giving a free cash flow of -$7.30M.
| Operating Cash Flow | -7.30M |
| Capital Expenditures | -4 |
| Free Cash Flow | -7.30M |
| FCF Per Share | -83.88 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
THAR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -5003.74% |
| FCF Yield | -229.55% |
Analyst Forecast
The average price target for THAR is $17, which is 694.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $17 |
| Price Target Difference | 694.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on May 28, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | May 28, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -14.15 |
| Piotroski F-Score | 2 |